1. Home
  2. BEAM vs BITF Comparison

BEAM vs BITF Comparison

Compare BEAM & BITF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Beam Therapeutics Inc.

BEAM

Beam Therapeutics Inc.

HOLD

Current Price

$28.54

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Logo Bitfarms Ltd.

BITF

Bitfarms Ltd.

HOLD

Current Price

$2.88

Market Cap

2.0B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
BEAM
BITF
Founded
2017
2017
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
2.0B
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
BEAM
BITF
Price
$28.54
$2.88
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
12
3
Target Price
$48.09
$3.67
AVG Volume (30 Days)
1.4M
39.0M
Earning Date
02-24-2026
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$55,701,000.00
$276,409,000.00
Revenue This Year
N/A
$47.67
Revenue Next Year
$26.52
$0.20
P/E Ratio
N/A
N/A
Revenue Growth
N/A
94.98
52 Week Low
$13.53
$0.67
52 Week High
$35.25
$6.60

Technical Indicators

Market Signals
Indicator
BEAM
BITF
Relative Strength Index (RSI) 60.68 53.59
Support Level $26.25 $2.32
Resistance Level $28.00 $2.95
Average True Range (ATR) 1.44 0.21
MACD -0.07 0.06
Stochastic Oscillator 57.34 90.14

Price Performance

Historical Comparison
BEAM
BITF

About BEAM Beam Therapeutics Inc.

Beam Therapeutics Inc is a biotechnology company committed to creating a new class of precision genetic medicines based on its proprietary base editing technology, with a vision of providing lifelong cures to patients suffering from serious diseases. The company is focused on its programs in the hematology and genetic disease portfolios, which comprise different product candidates in its pipeline, such as BEAM-101, which is being developed to target Sickle Cell Disease, BEAM-302, a liver-targeting lipid nanoparticle, being developed to target Alpha-1 antitrypsin deficiency, and other drug candidates including BEAM-302, BEAM-103 & 104. The company views its operations and manages its business in one operating segment, operating exclusively in the United States.

About BITF Bitfarms Ltd.

Bitfarms Ltd engaged in the cryptocurrency Mining industry mainly consists of selling its computational power used for hashing calculations for cryptocurrency mining in multiple jurisdictions. Its geographic operations are currently located in Canada, the United States, Argentina. It owns and operates server farms comprised of computers designed to validate transactions on the Bitcoin Blockchain.

Share on Social Networks: